Bictegravir 1611493-60-7

Nkọwa dị mkpirikpi:

Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
Bictegravir 1611493-60-7 Ọrịa HIV-1 Sayensị Gilead Ọnwa Iri na Abụọ 19, 2033


Nkọwa ngwaahịa

Mkpado ngwaahịa

Nkọwa ngwaahịa

Nkọwa

Bictegravir bụ akwụkwọ akụkọ, onye na-egbochi nje HIV-1 na IC50 nke 7.5 nM.

Na Vitro

Bictegravir (BIC) na-egbochi ọrụ mbufe eriri na IC50 nke 7.5± 0.3 nM.N'ihe metụtara mgbochi ya nke ọrụ mbufe strand, Bictegravir bụ ihe na-egbochi ike nke 3.'-Nhazi ọrụ nke HIV-1 IN, yana IC50 nke 241±51 nM.Bictegravir na-eme ka mkpokọta 2-LTR dị gburugburu ~ 5-n'ụzọ kwekọrọ na njikwa a na-akwa emo ma na-ebelata ọnụ ọgụgụ nke ngwaahịa njikọta na sel ndị butere site na 100 okpukpu.Bictegravir na-egbochi nje HIV-1 nke ọma na mkpụrụ ndụ MT-2 na MT-4 nwere EC50s nke 1.5 na 2.4 nM, n'otu n'otu.Bictegravir na-egosipụta mmetụta antiviral siri ike na CD4 + T lymphocytes bụ isi na macrophages nke monocyte enwetara, yana EC50s nke 1.5.±0.3 nM na 6.6±4.1 nM, n'otu n'otu, nke tụnyere ụkpụrụ enwetara n'ahịrị T-cell[1].

MCE akwadobeghị izi ezi nke ụzọ ndị a n'onwe ya.Ha bụ naanị maka ntụnye aka.

Nọmba NCT Onye nkwado Ọnọdụ Ụbọchị mmalite

Usoro

NCT03998176 Mahadum Nebraska | Gilead Sciences HIV-1 - ọrịa Ọktoba 9, 2019

Agba 4

NCT03789968 Thomas Jefferson University | Mahadum Maryland, College Park | Health University Indiana | Ụlọ Ọgwụ Ụlọ Ọgwụ Brooklyn | Mahadum Illinois na Chicago | Mahadum Nova Southeast | Mahadum California, San Francisco HIV + AIDS Septemba 1, 2019
NCT04249037 Mahadum Colorado, Denver | Gilead Sciences HIV + AIDS Maachị 1, 2020

Ọ metụtaghị

NCT04132674 Ụlọ Ọrụ Ọrịa na-efe efe nke Vancouver Nje Virus Immunodeficiency mmadụ nke mbụ | Ojiji ọgwụ Nọvemba 26, 2018

Agba 4

NCT04054089 Cristina Mussini | Mahadum nke Modena na Reggio Emilia Ọrịa HIV Septemba 2019

Agba 4

NCT04155554 Azienda Ospedaliera Universitaria Senese|Catholic University of the Sacred Heart|Ospedale Policlinico San Martino|Azienda Ospedaliera San Paolo|Ospedale Amedeo di Savoia HIV-1 - ọrịa Jenụwarị 29, 2020

Nkeji 3

NCT02275065 Sayensị Gilead Ọrịa HIV-1 Ọktoba 2014

Agba 1

NCT03711253 Mahadum Southern California Ọrịa HIV dị oke njọ Ọktoba 14, 2019

Agba 4

NCT02400307 Sayensị Gilead HIV Eprel 17, 2015

Agba 1

NCT03499483 Fenway Community Health Mgbochi HIV Jenụwarị 24, 2019

Agba 4

NCT03502005 Midland Research Group, Inc.|Gilead Sciences Nje Virus Immunodeficiency mmadụ Maachị 1, 2018

Agba 4

Ọdịdị chemical

Bictegravir-1611493-60-7

Asambodo

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

njikwa mma

Quality management1

Atụmatụ18Ọrụ nlebanya na-agbanwe agbanwe nke akwadoro4, na6A na-akwado ọrụ ngo.

Quality management2

Usoro njikwa ogo mba ụwa dị elu etinyela ntọala siri ike maka ire ahịa.

Quality management3

Nlekọta dị mma na-aga n'ihu na usoro ndụ nke ngwaahịa ahụ niile iji hụ na ịdịmma na mmetụta ọgwụgwọ.

Quality management4

Ndị otu Regulatory Affairs ndị ọkachamara na-akwado ịdịmma chọrọ n'oge ngwa na ndebanye aha.

njikwa mmepụta

cpf5
cpf6

Ahịrị nkwakọ ngwaahịa Korea Countec

cpf7
cpf8

Taiwan CVC ahịrị nkwakọ ngwaahịa

cpf9
cpf10

Line CAM Board Ịtali

cpf11

Igwe na-akpakọrịta Fette German

cpf12

Ihe nchọpụta mbadamba ihe ngosi nke Japan

cpf14-1

Ụlọ njikwa DCS

Onye mmekọ

Mmekọrịta mba ụwa
International cooperation
Imekọ ihe ọnụ n'ụlọ
Domestic cooperation

  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya

    Ụdị ngwaahịa